Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maschmeyer Group is a private venture capital and investment holding organization associated with entrepreneur Carsten Maschmeyer. The group serves as an umbrella for multiple investment vehicles and activities, including venture investing and growth capital, with interests spanning software, technology, fintech, insurtech, and selectively healthcare and life sciences. Available public information indicates it is primarily an investor rather than an operating biotech, pharma, or healthcare company. As a result, it does not appear to have an internal therapeutic pipeline, drug development programs, or proprietary clinical-stage assets. For biotech diligence purposes, Maschmeyer Group is best characterized as a financially active investment platform with occasional exposure to health and life science companies rather than a therapeutic developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maschmeyer Group.